A Promising New Era in Stroke Prevention: Anti-Clotting Drug Reduces Bleeding in Atrial Fibrillation Patients
Summary A novel anti-clotting drug, abelacimab, has shown remarkable success in reducing bleeding events in patients with atrial fibrillation, a common heart condition that increases stroke risk. This breakthrough offers a safer alternative to current […]
